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Abstract
Introduction. Only a few authors conducted comparative analyses of early and late health-related quality of life (HRQoL) 
depending on gender of patients with acute coronary syndrome (ACS) and discussed the factors affecting the late 
HRQoL in this group. We hypothesized that women with ACS are characterised by worse long-term (6th month follow-up 
HRQoL) after percutaneous coronary intervention (PCI).
To examine the dynamics of changes in HRQoL between the baseline and 6th month follow-up after ACS, depending on 
gender, and to determine sociodemographic and clinical predictors at baseline, which may have an impact on 6th month 
follow-up assessment of HRQoL.
Material and methods. The study included 140 consecutive patients (70 women and 70 men) with ACS who were sub-
jected to PCI. The patients were divided depending on gender: group I (n = 70) — women with ACS without ST elevation 
(NSTEMI; n = 14) and those with ST elevation (STEMI; n = 56); group II (n = 70) — men with ACS without ST elevation 
(NSTEMI; n = 9) and those with ST elevation (STEMI; n = 61).
HRQoL was assessed two times (at baseline and 6th month follow-up) of Short Form 36 (SF-36) questionnaire, and the effect 
of sociodemographic and clinical factors on physical (PCS) and mental (MCS) component summary scores was evaluated.
Results. Compared to men, women presented with significantly lower PCS and MCS scores, both at baseline and at 
6th month-follow-up. On univariate analysis, significantly lower PCS scores were observed among women, patients older 
than 70 years, physically inactive, not smoking, retired, and diagnosed with depressive symptoms. In contrast, we did not 
reveal any significant effects of the analysed variables on MCS on univariate analysis. The multivariate stepwise logistic 
regression analysis identified female gender and age > 70 as significant predictors of 6th month follow-up HRQoL in both 
PCS and MCS of SF-36. Moreover, marital status, and depression turned out to negatively affect the HRQoL in PCS. Ad-
justed odds ratio revealed that women were at three- and two-fold greater risk of decreased PCS and MCS, respectively.
Conclusions. Among the patients with ACS, women showed lower HRQoL than men, both at baseline and at 6th month fol-
low-up. Both women and men showed improvement in PCS at 6th month follow-up but MCS improvement was observed only 
for women. The significant baseline predictors of 6th month follow-up HRQoL were female gender, age and marital status.
Key words: health-related quality of life, acute coronary syndrome, gender differences
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Introduction
The studies from the last decade centred around long-term 
health-related quality of life (HRQoL) in many of the chronic 
diseases [1]. HRQoL, defined as the impact of disease on 
a patient’s functioning as perceived and reported by the 
patient, has gained increasing recognition as an important 
endpoint. HRQoL is a multidimensional construct, encom-
passing aspects of psychological, social, and physical well-
-being, and should reflect a patient’s, rather than the health 
care professionals, subjective assessment of well-being [1].
Among factors determining HRQoL in patients with 
coronary artery disease, angina symptoms, presence of 
cardiovascular risk factors, such as arterial hypertension, 
smoking, hyperlipidaemia, diabetes, obesity and depressive 
symptom, socioeconomic conditions, education, marital 
status, level of social support, and applied pharmacothe-
rapy and invasive treatment are listed [2, 3].
Low levels of HRQoL among patients with coronary ar-
tery disease are a potential “risk factor” of cardiovascular 
events, which more than triple the probability of death due 
to cardiovascular causes [4]. While there are numerous 
studies of late HRQoL in stable coronary artery disease 
[5, 6], only few authors addressed this issue in individuals 
with acute coronary syndrome (ACS) [7–9].
Studies concerning invasive interventions in ACS are 
mainly oriented on the assessment of the effect of therapy 
on mortality and incidence of coronary events. However, 
only few of them evaluated the impact on HRQoL [7].
The studies on the impact of gender on HRQoL outcome 
are limited and inconclusive [8, 9].
There is some controversy as to whether percutane-
ous coronary intervention (PCI) in ACS is beneficial either 
for women, or men. The evidence supports the thesis on 
a lack of differences in HRQoL in regards to gender [8, 10]; 
nevertheless, there are studies indicating lower values of 
HRQoL in women [5, 9].
Only a few authors conducted comparative analyses of 
early and late HRQoL depending on gender of patients with 
ACS and discussed the factors affecting the late HRQoL in 
this group [11].
We hypothesized that women with ACS are characteri-
sed by worse long-term HRQoL.
The aim of the study was to examine the dynamics of 
changes in HRQoL between the baseline and 6th month 
follow-up, depending on gender, and to determine socio-
-demographic and clinical predictors at baseline, which may 
have an impact on 6th month follow-up HRQoL.
Material and methods
The study included 140 consecutive patients (70 women 
and 70 men) admitted to the Coronary Intensive Care Unit 
due to ACS between September 2008 and March 2009. 
All the patients underwent PCI and met the inclusion 
criteria. The clinical diagnosis of ACS was based on the 
European Society of Cardiology (ESC) guidelines [12, 
13]. All patients gave informed consent for participating 
in the study.
The patients were divided into groups depending on 
gender: 1) Group I (n = 70) — women aged 44–95 ye-
ars (c– = 67.6) with acute coronary syndrome without ST 
elevation (NSTEMI; n = 14), who underwent early invasive 
treatment, and those with ST elevation (STEMI; n = 56), who 
underwent primary coronary angioplasty; and 2) Group II 
(n = 70) — men aged 32–95 years (c– = 59.2) with acute 
coronary syndrome without ST elevation (NSTEMI; n = 9), 
who underwent early invasive strategy, and those with ST 
elevation (STEMI; n = 61), who underwent primary coronary 
angioplasty.
STEMI was defined as the presence of: 1) typical chest 
pain lasting > 30 minutes, 2) ST-segment elevation ≥ 2 mm 
in contiguous chest leads and/or ST-segment elevation at 
≥ 1 mm in ≥ 2 standard leads, or new left bundle branch 
block, and 3) positive cardiac necrosis markers [12].
NSTEMI was defined as the presence of: 1) typical chest 
pain, 2) absence of ST-segment elevation, and 3) positive 
cardiac necrosis markers [13].
Only the patients who underwent PCI were included 
in the analysis. All patients with acute coronary syndrome 
(STEMI, NSTEMI), demonstrating sufficient mental awa-
reness and enough knowledge of Polish to complete the 
questionnaire were enrolled in the study.
Patients admitted with severe disturbances, such as 
cardiogenic shock, pulmonary oedema, and ventricular 
fibrillation, patients with very limited HRQoL due to non-
-cardiac diseases, such as chronic obstructive pulmonary 
disease (COPD), stroke, cancer, mental disorder, as well 
as patients addicted to alcohol and other psychoactive 
substances were excluded from the study.
In the present study, the assessment of HRQoL was 
carried out twice: in the 1st week (baseline) after PCI and 
at 6th month-follow-up after the procedure. Both inquiries 
were completed in the presence of an examining person. 
The examination was performed by a trained nurse. The 
second assessment was conducted at the hospital’s Car-
diology Outpatient Department by the same person. A total 
of 67 women and 70 men took part in the follow-up; three 
women died within 5–6 months after the initiation of the 
study (from non-cardiovascular causes).
The protocol of the study was approved by the Bioethics 
Committee of Wroclaw Medical University (decision no. 
KB-234/2009).
We used the analysis of medical documentation deter-
mining the patient’s clinical state and case data based on 
medical history. Assessment of HRQoL was conducted with 
the Polish version of general HRQoL Short Form 36 (SF-36) 
questionnaire. We used the SF-36 questionnaire under 
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the license No. H1-051105-2244 issued by Quality Metric 
Incorporated, USA.
SF-36 questionnaire is one of the most commonly used 
tools for determining the HRQoL of both various groups of 
patients and the general population. The questionnaire 
consists of 36 items used for testing two domains: 1) phy-
sical (physical component summary, PCS), consisting of 
four subscales: physical functioning (PF), role limitations 
due to physical problems (RP), bodily pain (BP), and gene-
ral health perception (GH), and 2) mental (MCS, mental 
component summary,), also comprising four subscales: 
vitality (VT), social functioning (SF), role limitation due to 
emotional problems (RE), and subjective assessment of 
mental health (MH). The results oscillate between 0 and 
100 in each category, with the lower scores corresponding 
to poorer QoL. The SF-36 scale has shown satisfactory psy-
chometric parameters, and has Polish validation [14]. The 
SF-36 health status survey is a standardized and validated 
instrument, recommended by the American Association 
of Cardiovascular and Pulmonary Rehabilitation, used for 
evaluating HRQoL in patients with cardiovascular disorders 
[14]. The SF-36 questionnaire has been widely used in 
various countries with different population groups, and 
with patients with both medical and psychiatric conditions. 
Transversal studies have shown that the SF-36 is a valid 
and reliable instrument for detecting differences between 
groups defined by age, sex, socio-economic status, and 
clinical condition [1].
Baseline depressive symptoms was evaluated using the 
Beck Depression Inventory which is a self-scoring test for 
symptoms and severity of depression composed of 21 ques-
tions and offering four answers scored 0 to 3 points. A score 
≥ 10 indicates moderate symptoms of depression. The 
higher the score, the worse the mental condition of the 
patient. None of the patients had history of depression, 
and has not been administered antidepressants.
In order to investigate the correlation between depressi-
ve symptoms and the HRQoL, the patients were divided into 
two groups. All patients who scored more than 10 points 
on the Beck Depression Inventory were placed in the group 
with depressive symptoms. This approach was consistent 
with the guidelines of the authors of the Index, and has 
been used in many previous studies [15, 16].
Patients’ sociodemographic data concerning gender, 
age, marital status, education, and occupational activity 
were collected. All respondents were given questionnaires 
containing comprehensive information about the conduc-
ted study, asked to express their consent, and assured of 
absolute anonymity.
We evaluated the effect of sociodemographic factors, 
such as gender, age, marital status, education, and oc-
cupational activity on HRQoL. Additionally, variables which 
may affect HRQoL were subjected to analysis of ACS type 
(STEMI or NSTEMI) and risk factors, and levels of depressive 
symptoms. The list of potential risk factors included tobacco 
smoking, obesity (BMI, body mass index ≥ 30 kg/m2) or 
overweight (BMI = 25–29.9 kg/m2), abdominal obesity 
identified according to guidelines (waist circumference 
≥ 80 cm in women and ≥ 94 cm in men) [17], dyslipidaemia 
according to ESC criteria (triglycerides ≥ 150 mg/dl, 
cholesterol HDL [high-density lipoprotein] < 40 mg/dl or 
1.0 mmol/l in men and < 45 mg/dl or 1.3 mmol/l in women, 
total cholesterol ≥ 190 mg/dl, cholesterol LDL [low-density 
lipoprotein] ≥ 115 mg/dl), diabetes (diagnosed on the basis 
of regular administration of hypoglycaemic drugs and/or 
results of laboratory tests), arterial hypertension (SBP, sy-
stolic blood pressure ≥ 140 mm Hg and/or DBP, diastolic 
blood pressure ≥ 90 mm Hg in measurements conducted 
twice, or regular administration of antihypertensive drugs 
[17]. Physical activity on admission was analysed as 
a binary variable (non-active vs. moderately active). The 
evaluation was based on our original questionnaire. The 
activity (walking, cycling) undertaken at least three times 
a week for less than 30 minutes, was considered as no 
activity, and the activity undertaken more than three times 
weekly, with each session lasting at least 30 minutes, was 
considered as moderate.
Statistical analysis
Statistical analysis was conducted with STATISTICA 9.0 
package (StatSoft, USA). The type of distribution was 
verified for all tested variables with the Shapiro-Wilk’s 
test. P = 0.05 was considered as critical significance 
level. For measurable (quantitative) variables, arithmetic 
means, standard deviations, medians, and ranges were 
calculated, and statistical characteristics of qualitative 
variables were presented as their percentage distri-
butions. We used contingency tables and chi-square 
test (c2) or odds ratio for the analysis of qualitative 
variables. Comparisons of quantitative variables in two 
independent groups (e.g. F vs. M) were performed with 
the Mann-Whitney U-test, and dependent variables were 
compared with the Wilcoxon signed-rank test. In order to 
compare mean values of variables which did not meet 
the criteria of variance analysis, Kruskal-Wallis test was 
used. Taking into account their deviation from standard 
distributions, we used Spearman’s rank correlation 
coefficient for assessing the power and direction of 
association between the tested variables (standards 
of HRQoL and some clinical factors). The Spearman’s 
correlation coefficient was calculated for each pair of 
variables, and the level p < 0.05 was regarded as stati-
stically significant.
The results of the SF-36 were presented as cardinality 
and percentages in tables four-pole cross (cross tabulation). 
The strength of the analysed correlation dichotomous va-
riables estimated by the odds ratio and 95% confidence 
intervals for the odds ratio. The adjusted Mantel-Haenszel 
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odds ratio and its 95% confidence interval were calculated 
in order to exclude potential effect of confounding variables.
Results
Patient characteristics
Demographic and clinical characteristics of the studied 
group are shown in Table 1. Women with ACS were signifi-
cantly older than men, by 8 years on average (67.6 ± 12.7 
vs. 59.2 ± 10.7; p < 0.001). Compared to men, women 
suffered more often from arterial hypertension (71.4% vs. 
37.1%; p = 0.001), diabetes (40% vs. 21.4%; p = 0.05), 
and hyperlipidaemia (64% vs. 50%; ns). While obesity (BMI 
> 30) occurred more often among women than among men 
(52.8% vs. 41.4%; p = 0.05), the mean values of BMI did 
not differ significantly between genders (30.5 ± 5.5 vs. 29.6 
± 3.4; p = ns). Analysis of abdominal obesity (WHR, waist 
to hip ratio > 0.85) indicated that it occurred more often 
among men (95.7% vs. 65.7% in women; p < 0.001). Also, 
the mean value of WHR was higher for men (0.99 ± 0.06 
vs. 0.85 ± 0.01; p < 0.001). Women were less physically 
active than men. As many as 84.3% of women confessed 
to no activity (Table 1).
Over half of the women lived alone (57.1% vs. 21.5%; 
p < 0.001). As many as 64% of men and 37% of women 
admitted to active tobacco smoking. Women were less edu-
cated than men (35.7% women vs. 11.4% men, p < 0.01) 
and more likely to not work or be retired (82.9% vs. 61.4% 
in men, p < 0.01). The analysis of depressive symptoms 
indicated that 74.3% of women vs. 51.4% of men achie-
ved Beck Depression Inventory (BDI) score > 10 points; 
p = 0.01 (Table 1).
All patients were on optimal pharmacological treat-
ment for secondary prevention, in accordance with ESC 
guidelines [12, 13].
Comparison of PCS and MCS  
of SF-36 HRQoL — related to gender
Basic statistical characteristics of the results of HRQoL 
assessment within the analysed groups are shown in Fi-
gures 1 and 2. Compared to men, women presented with 
significantly lower values of physical component summary 
(PCS), both at baseline (1st week; 28.7 ± 8.1 in women vs. 
36.2 ± 11.4 in men; p < 0.001) and at 6th month-follow-up 
(40.1 ± 11.3 vs. 48.2 ± 8.5; p < 0.001; Fig. 1). Analysis of 
the dynamics within PCS showed a favourable increasing 
trend in both groups: from 28.7 ± 8.1 to 40.1 ± 11.3 in 
women (p < 0.001) and from 36.2 ± 11.4 to 48.2 ± 8.5 in 
men (p < 0.001; Fig. 1).
Compared to men, women showed lower values of men-
tal component summary (MCS), both at baseline (1st week; 
36.7 ± 11.1 in women vs. 44.8 ± 10.8 in men; p < 0.001) 
and at 6th month follow-up (40.5 ± 8.8 vs. 42.9 ± 6.6; 
p = 0.105; Fig. 2). Analysis of dynamics within MCS indica-
ted a favourable increasing trend only in women (from 36.7 
± 11.1 to 40.5 ± 8.8; p < 0.005). In the group of men, the 
values of MCS showed a decreasing, albeit insignificant, 
trend (44.8 ± 10.8 vs. 42.9 ± 6.6; p = 0.087; Fig. 2).
Comparison of subscales of PCS and MCS 
— related to gender
Compared to men, women exhibited significantly lower valu-
es in all domains of SF-36 questionnaire, both at baseline 
(1st week) and at the 6th month follow-up (Fig. 3).
The analysis of dynamics indicated a positive increa-
sing trend in all domains of PCS (consisting of subscales: 
PF, RP, BP, and VT) and MCS (consisting of subscales: SF, 
RE, MH, and GH) in the group of women. In contrast, in 
the case of men the positive trend was observed in all 
subscales except MH.
Women with ACS reported lower HRQoL scores than 
men, both at baseline (1st week) and at 6th month follow-up. 
However long-term improvement of HRQoL was observed 
in both genders, in terms of PCS.
In addition, differences in the results of both groups 
were confirmed by subtracting the results of women from 
results of men, and subsequent use of the confidence 
interval (CI) 95%. The results are presented in Table 2.
After 6 months, the difference between the PCS values 
of men and women did not change significantly (p > 0.05). 
At the same time, the difference in the MCS decreased 
significantly (p < 0.001), suggesting superior effect of the 
therapy in women (Table 2).
Analysis of 6th month follow-up PCS  
and MCS related to the presence  
of baseline variables
Lower HRQoL in the PCS domain was observed among women 
(40.1 ± 11.3 vs. 48.2 ± 8.5; p < 0.001), individuals older than 
70 years (41.7 ± 11.0 vs. 47.3 ± 9.6; p < 0.01), with NSTEMI 
(38.2 ± 11.4 vs. 45.3 ± 10.3 vs. p < 0.01), physically ina-
ctive (43.2 ± 10.1 vs. 47.4 ± 10.9; p < 0.05), not smoking 
(37.6 ± 11.0 vs. 46.4 ± 9.7; p < 0.001), retired (41.5 ± 
± 10.4 vs. 50.9 ± 8.5; p < 0.001), lone (40.3 ± 10.5 vs. 
46.6 ± 10.2; p < 0.001) and diagnosed with depressive 
symptoms (BDI > 10 pts; 42.3 ± 10.5 vs. 46.7 ± 10.6; 
p = 0.01). In contrast, we did not reveal any significant 
effects of the analysed variables on MCS in univariate 
analysis (Table 3).
The patients were divided into subgroups depending 
on median values of PCS and MCS. Lower value of PCS 
was defined as < 46.45 and higher value was defined as 
≥ 46.45, respectively, lower value of MCS was defined as 
< 43.44 and higher value was defined as ≥ 43.44. The 
effect of analysed variables on lower values of 6th month 
follow-up HRQoL in the area of PCS and MCS domains was 
showed in Table 4. The following baseline variables proved 
to be significant prognostic factors of lower 6th month 
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I vs. II 
p
n (%) n (%) n (%)
Age
mean ± SD 67.6 ± 12.7 59.2 ± 10.7 63.4 ± 12.5 < 0.001
ACS ns
STEMI 56 80 60 87 117 83.6
NSTEMI 14 20 10 13 23 16.4
Marital status
Married 30 42.9 55 78.6 85 60.7 < 0.001
Lone 40 57.1 15 21.5 55 39.3
Physical activity
None 59 84.3 49 70 108 77.1 ns
Moderate 11 15.7 21 30 32 22.9
Occupational activity
Employed 12 17.1 27 38.6 39 27.9 < 0.01
Not employed/retired 58 82.9 43 61.4 101 72.1
Smoking tobacco
Non-smoker 44 63 25 36 69 49 < 0.001
Smokes now 26 37 45 64 71 51
Diabetes 28 40 15 21.4 43 30.7 < 0.05
Arterial hypertension 50 71.4 26 37.1 76 54.3 < 0.001
Hyperlipidaemia 45 64 35 50 114 81.4 ns
BMI [kg/m2]
mean ± SD 30.5 ± 5.5 29.6 ± 3.4 30.0 ± 4.6 ns
BMI [kg/m2]
> 25 9 12.9 9 12.9 18 12.9
25.1–30 24 34.3 32 45.7 56 40 < 0.05
30.1–35 37 52.8 29 41.4 66 47.1
Abdominal obesity
WHR > 0.85 46 65.7 67 95.7 113 < 0.001
WHR [cm/cm]
mean ± SD 0.85 ± 0.01 0.99 ± 0.06 0.92 ± 0.1 < 0.001
Education
Elementary 25 35.7 8 11.4 33 23.6
Occupational 15 21.4 40 57.1 55 39.3 < 0.01
Postgraduate 30 42.9 22 32.4 52 37.1
Depression 1st week
BDI ≤ 10 pts 18 25.7 34 48.6 52 37.1
BDI > 10 pts 52 74.3 36 51.4 88 62.9 0.01
SD — standard deviation; ACS — acute coronary syndrome; STEMI — acute coronary syndrome with ST elevation; NSTEMI — acute coronary syndrome without ST elevation; BMI — body mass index;  
WHR — waist to hip ratio; BDI — Beck Depression Inventory
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Figure 1. Mean and 95% confidence interval value within physical 
component summary (PCS) — the group of females and males 
in 1st week (baseline) and at 6th month follow-up; SF-36 — Short 
Form 36
Figure 2. Mean and 95% CI value within mental component 
summary (MCS) — the group of females and males in 1st week 
(baseline) and at 6th month follow-up; SF-36 — Short Form 36
Figure 3. Mean values in subscales of Short Form 36 (SF-36) — the group of females and males in 1st week and at 6th months follow-up: 
PF — physical functioning; RP — role limitations due to physical problems; BP — bodily pain; GH — general health perception; VT — vitality; 
SF — social functioning; RE — role limitation due to emotional problems; MH — mental health
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Table 2. Relative differences (with 95% confidence intervals) in physical component summary (PCS) and mental component summary 
(MCS) scores of men (M) and women (F)
SF-36 (points) M — F 
1st week
M — F 
6th months
1st week vs. 6th months 
P level
SF-36 PCS 7.5 (4.2 ÷ 10.8) 8.1 (4.8 ÷ 11.4) ns
SF-36 MCS 8.1 (4.4 ÷ 11.8) 2.4 (–0.2 ÷ 5.1) < 0.001
ns — not statistically significant
follow-up PCS domains (< 46.45): gender (OR, odds ratio 
= 2.86; 95%Cl = 1.44 ÷ 5.69), age (OR = 5.36; 95%Cl = 
2.42 ÷ 11.9), marital status (OR = 4.25; 95%Cl = 2.05 ÷ 
÷ 8.82), lack of physical activity (OR = 2.30; 95%Cl = 1.01 
÷ 5.23), non-smoking (OR = 3.55; 95%Cl = 1.55 ÷ 8.10), 
lack of occupational activity (OR = 3.58; 95%Cl = 1.60 ÷ 
÷ 7.97), and depression (OR = 2.73; 95%Cl = 1.34 ÷ 5.56). 
No significant prognostic factors of lower MCS (< 43.44) 
among the studied variables was found (Table 4).
The coefficients of linear correlation (r) between 
quantitative baseline characteristics of patients and their 
determined 6th month follow-up HRQoL are presented in 
Table 5. A negative correlation between 6th month follow-
-up PCS score and age (r = –0.394), depressive symptoms 
(r = –0.318), and the occurrence of abdominal obesity 
(r = –0.259) was shown among women. No significant 
correlation between 6th month follow-up MCS and other 
analysed variables was revealed. Significant negative 
correlations were revealed in men: between abdominal 
obesity and 6th month follow-up MCS (r = –0.239) and 
between depressive symptoms and 6th month follow-up 
PCS (r = –0.323; Table 5).
Baseline predictors of lower HRQoL  
at 6th month follow-up
Baseline variables that turned out to be significant in the 
univariate analysis were taken into account for the multi-
variate forward stepwise logistic regression analysis.
Adjusted odds ratios and their 95% confidence in-
tervals are presented in Table 6. Comparing the value 
of crude odds ratio (Model 1), women are at three-fold 
greater risk of lower 6th month follow-up PCS than men 
(ORMH = 2.86). Although, the value of odds ratio decreased 
after adjusting for confounding variables, such as age, 
marital status, and depression (Model 4). Female gender 
was still associated with two-fold greater risk of lower 
6th month follow-up PCS (Mantel-Haenszel odds ratio, 
ORMH = 2.11). Univariate analysis showed that the gender 
had no significant effect on the lower value of MCS, but 
in multivariate analysis, after adjusting for age, marital 
status and depression probability of lower 6th month 
follow-up MCS was two-fold-greater among women than 
in men (ORMH = 1.83) (Table 6).
Discussion
Dynamics of HRQoL  
— gender-specific differences
PCI have been shown to improve the short- and long-term 
outcomes in men and women with ACS. However, it still 
remains unclear whether the PCI exerts as favourable effect 
on HRQoL for women as for men [18].
Despite numerous studies analysing the effect of PCI on 
HRQoL in patients after ACS, the data on the gender-specific 
dynamics of HRQoL are limited and inconclusive [9, 19, 20]. 
Previous studies revealed that HRQoL after ACS is poorer 
in women than in men [5]; however, some authors did not 
observe such gender-related differences [8]. While some 
data on gender-related differences in ACS risk profile are 
available [21], little is known on the specificity of adaptation 
after the disease in men and women. Our study adds to the 
ongoing discussion on whether there are gender-related 
differences in HRQoL after ACS.
We revealed that HRQoL scores of women are lower 
than in men, both at baseline and at 6th month-follow-up. 
Nevertheless, the relative increase of HRQoL in all domains 
of SF-36 questionnaire was greater among women. Our 
results are consistent with the findings of other authors, 
who also revealed that HRQoL scores among women after 
ACS are lower than in men [9, 20]. Pettersen et al. [20] 
analysed a group of 408 patients 2.5 years after ACS and 
revealed that women had considerably poorer HRQoL 
scores than men in each domain of SF-36 questionnaire. 
Mortensen et al. [9] assessed HRQoL and depression in 
1351 patients with NSTEMI, one and twelve months after 
ACS, with regards to the therapeutic approach (invasive 
treatment vs. fibrinolysis). They revealed that after invasive 
treatment HRQoL of women was lower than in men [9]. Also 
Westin et al. observed lower values of HRQoL in women 
both one month and one year after ACS [5].
We observed improvement of HRQoL in both women 
and men; however, dissimilar improvement patterns were 
recorded. Although improvement in PCS was observed for 
both genders, the scores of women were lower, plausibly, 
due to the exacerbation of somatic symptoms. Concerning 
MCS on follow-up, increased scores were observed solely 
for women, and a decrease was documented for men.
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Table 3. Mean values of physical component summary (PCS) and mental component summary (MCS) scores at 6th month follow-up de-
pending on the presence of analysed baseline variables
Variables SF-36 PCS P level SF-36 MCS P level
Sex
Female (n = 70) 40.1 ± 11.3 < 0.001 40.5 ± 8.8 ns
Male (n = 70) 48.2 ± 8.5 < 0.001 42.9 ± 6.6
Age (years)
< 70 (n = 61) 47.3 ± 9.6 < 0.01 40.1 ± 7.7 ns
≥ 70 (n = 79) 41.7 ± 11.0 42.3 ± 8.0
ACS
STEMI (n = 117) 45.3 ± 10.3 < 0.01 41.4 ± 8.0 ns
NSTEMI (n = 23) 38.2 ± 11.4 43.4 ± 7.4
Marital status
Married (n = 85) 46.6 ± 10.2 < 0.001 41.8 ± 7.4 ns
Lone (n = 55) 40.3 ± 10.5 41.5 ± 8.6
Exposure to stress
Yes (n = 53) 46.6 ± 10.1 < 0.05 41.3 ± 7.8 ns
No (n = 87) 42.7 ± 10.9 41.9 ± 7.9
Physical activity
None (n = 108) 43.2 ± 10.1 < 0.05 41.3 ± 8.0 ns
Moderate (n = 32) 47.4 ± 10.9 43.0 ± 7.4
Smoking tobacco
Non-smoker (n = 36) 37.6 ± 11.0 < 0.001 41.6 ± 8.6 ns
Smokes now (n = 104) 46.4 ± 9.7 41.7 ± 7.7
Occupational activity
Employed (n = 39) 50.9 ± 8.5 < 0.001 41.9 ± 6.5 ns
Not employed/retired (n = 101) 41.5 ± 10.4 41.6 ± 8.4
Diabetes
Yes (n = 66) 43.1 ± 10.6 ns 41.8 ± 7.5 ns
No (n = 74) 45.1 ± 10.8 41.6 ± 8.3
Arterial hypertension
Yes (n = 102) 43.4 ± 11.0 ns 41.6 ± 7.8 ns
No (n = 38) 46.1 ± 9.8 41.9 ± 8.1
Hyperlipidaemia
Yes (n = 82) 43.4 ± 11.5 ns 41.0 ± 8.1 ns
No (n = 58) 46.1 ± 9.4 42.6 ± 7.6
BMI [kg/m2]
≤ 25 (n = 19) 44.6 ± 8.9 ns 40.1 ± 9.9 ns
25.1 to 30 (n = 55) 45.8 ± 10.7 42.5 ± 8.1
≥ 30.1 (n = 66) 42.6 ± 11.2 41.5 ± 7.0
WHR [cm/cm]
< 0,8 (F) or < 0.9 (M) (n = 23) 41.3 ± 12.3 ns 39.9 ± 9.7 ns
> 0.8 (F) or > 0.99 (M) (n = 117) 44.7 ± 10.4 42.1 ± 7.5
Education
Elementary (n = 88) 43.1 ± 11.1 ns 42.1 ± 7.7 ns
Occupational (n = 37) 45.2 ± 10.1 41.1 ± 8.2
Postgraduate (n = 15) 47.8 ± 9.7 40.7 ± 8.2
Depression 1st week
Yes (BDI > 10 pts) (n = 88) 42.3 ± 10.5 0.01 40.9 ± 8.6 ns
No (BDI ≤ 10 pts) (n = 52) 46.7 ± 10.6 43.1 ± 6.2
SF-36 — Short Form 36; ns — not statistically significant; ACS — acute coronary syndrome; STEMI  — acute coronary syndrome with ST elevation; NSTEMI  — acute coronary syndrome without ST elevation;  
BMI — body mass index; WHR — waist to hip ratio; BDI — Beck Depression Inventory
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Table 4. Baseline predictors of lower physical component summary (PCS) and mental component summary (MCS) — results of univariate 
analysis














Female (n = 70) 44 (62.9%) 26 (37.1%) OR = 2.86 39 (55.7%) 31 (44.3%) OR = 1.58
Male (n = 70) 26 (37.1%) 44 (62.9%) (1.44 ÷ 5.69) 31 (44.3%) 39 (55.7%) (0.81 ÷ 3.08)
Age (years)
> 70 (n = 46) 35 (50.0%) 11 (15.7%) OR = 5.36 19 (27.1%) 27 (38.6%) OR = 0.59
≤ 70 (n = 94) 35 (50.0%) 59 (84.3%) (2.42 ÷ 11.9) 51 (72.9%) 43 (61.4%) (0.29 ÷ 1.21)
ACS
NSTEMI (n = 23) 15 (21.4%) 8 (11.4%) OR = 2.11 10 (14.3%) 13 (18.6%) OR = 0.73
STEMI (n = 117) 55 (78.6%) 62 (88.6%) (0.83 ÷ 5.37) 60 (85.7%) 57 (81.4%) (0.30 ÷ 1.80)
Marital status
Lone (n = 55) 39 (55.7%) 16 (22.9%) OR = 4.25 25 (35.7%) 30 (42.9%) OR = 0.74
Married (n = 85) 31 (44.3%) 54 (77.1%) (2.05 ÷ 8.82) 45 (64.3%) 40 (57.1%) (0.38 ÷ 1.46)
Physical activity
None (n = 108) 59 (84.3%) 49 (70.0%) OR = 2.30 55 (78.6%) 53 (75.7%) OR = 1.18
Moderate (n = 32) 11 (15.7%) 21 (30.0%) (1.01 ÷ 5.23) 15 (21.4%) 17 (24.3%) (0.53 ÷ 2.59)
Smoking tobacco
Non-smoker (n = 36) 26 (37.1%) 10 (14.3%) OR = 3.55 17 (24.3%) 19 (27.1%) OR = 0.86
Smokes now (n = 104) 44 (62.9%) 60 (85.7%) (1.55 ÷ 8.10) 53 (75.7%) 51 (72.9%) (0.40 ÷ 1.84)
Occupational activity
Not employed/retired (n = 101) 59 (84.3%) 42 (60.0%) OR = 3.58 49 (70.0%) 52 (74.3%) OR = 0.81
Employed (n = 39) 11 (15.7%) 28 (40.0%) (1.60 ÷ 7.97) 21 (30.0%) 18 (25.7%) (0.39 ÷ 1.69)
Hypertension
Yes (n = 102) 53 (75.7%) 49 (70.0%) OR = 1.34 52 (74.3%) 50 (71.4%) OR = 1.16
No (n = 38) 17 (24.3%) 21 (30.0%) (0.63 ÷ 2.82) 18 (25.7%) 20 (28.6%) (0.55 ÷ 2.44)
Diabetes
Yes (n = 66) 36 (51.4%) 30 (42.9%) OR = 1.41 35 (50.0%) 31 (44.3%) OR = 1.26
No (n = 74) 34 (48.6%) 40 (57.1%) (0.73 ÷ 2.75) 34 (50.0%) 39 (55.7%) (0.73 ÷ 2.75)
Hyperlipidaemia
Yes (n = 82) 45 (64.3%) 37 (52.9%) OR = 1.61 46 (65.7%) 36 (51.4%) OR = 1.81
No (n = 58) 25 (35.7%) 33 (47.1%) (0.82 ÷ 3.16) 24 (34.3%) 34 (48.6%) (0.92 ÷ 3.58)
BMI
> 30 (n = 66) 36 (51.4%) 30 (42.9%) OR = 1.41 37 (52.9%) 29 (41.4%) OR = 1.59
≤ 30 (n = 74) 34 (48.6%) 40 (57.1%) (0.73 ÷ 2.75) 33 (47.1%) 41 (58.6%) (0.81 ÷ 3.09)
WHR
< 0,8 (n = 50) 28 (40.0%) 22 (31.4%) OR = 1.45 26 (37.1%) 24 (34.3%) OR = 1.13
> 0.8 (n = 90) 42 (60.0%) 48 (68.6%) (0.73 ÷ 2.92) 44 (62.9%) 46 (65.7%) (0.57 ÷ 2.26)
Education
Elementary (n = 88) 48 (68.6%) 40 (57.1%) OR = 1.45 41 (58.6%) 47 (67.1%) OR = 0.69
Occupational (n = 52) 22 (31.4%) 30 (42.9%) (0.73 ÷ 2.92) 29 (41.4%) 23 (32.9%) (0.35 ÷ 1.38)
Depression 1st week
Yes (n = 88) 52 (74.3%) 36 (51.4%) OR = 2.73 45 (64.3%) 43 (61.4%) OR = 1.13
No (BDI ≤ 10 pts; n = 52) 18 (25.7%) 34 (48.6%) (1.34 ÷ 5.56) 25 (35.7%) 27 (38.6%) (0.57 ÷ 2.24)
Odds ratios significant at p < 0.05 marked with bold; SF-36 — Short Form 36; OR — odds ratio; CI — confidency interval; ACS — acute coronary syndrome; STEMI — acute coronary syndrome with ST elevation; 
NSTEMI — acute coronary syndrome without ST elevation; BMI — body mass index; WHR — waist to hip ratio; BDI — Beck Depression Inventory
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In women, beneficial changes in HRQoL were recorded 
within physical (PCS) and mental (MCS) component summa-
ry. For the men, an increase in HRQoL was observed within 
all PCS subscales, but only within three subscales (VT, SF, 
RE) of MCS; improvement of MH subscale of MCS was not 
recorded for male patients. To the best of our knowledge, 
our record is the first observation of the decrease of MH 
subscale and MCS domain results for men.
Although Brink et al. [19] reported similar results, with 
superior MCS in women, they did not record a decrease in 
MCS scores among men [19].
In our study, the decreased scores of MCS and lack of 
improvement within MH subscale in men can be explained 
by younger age of this group of patients and psychological 
consequences of this fact. Compared to older males, youn-
ger men assign lower values to HRQoL due to limitations 
in fulfilling professional and social activities, leading to 
frustration resulting from divergence between needs and 
opportunity to fulfil them, as well as due to less satisfactory 
sexual life [21].
Predictors of the HRQoL  
at 6th month follow-up
Female gender turned out to be a determinant of 6th 
month follow-up HRQoL. Multivariate analysis identified 
female gender as a significant predictor of lower HRQoL 
(both PCS and MCS) in the follow-up study. In univariate 
analysis, female gender turned out to be determinant only 
of lower PCS.
The reason for gender-specific differences in HRQoL in 
coronary artery disease is not clear. The differences can be 
explained by older age and greater number of concomitant 
Table 6. Multivariate stepwise logistic regression analysis of baseline predictors’ influence on 6th month follow-up physical component 





OR 95% CI OR 95% CI
Model 1
Female gender 2.86 1.44–5.69 1.58 0.81–3.08
Model 2
Female gender 1.92 0.89–4.15 2.06 0.99–4.30
Age > 70 4.29 1.76–10.5 0.45 0.21–0.99
Model 3
Female gender 1.94 1.11–3.39 1.99 1.17–3.39
Age > 70 2.90 1.64–5.14 0.53 0.31–0.93
Marital status — lone 3.12 1.76–5.50 0.71 0.41–1.23
Model 4
Female gender 2.11 1.36–3.28 1.83 1.19–2.81
Age >70 4.31 2.62–7.09 0.54 0.35–0.85
Marital status — lone 3.25 2.05–5.14 0.76 0.49–1.18
Depression BDI > 10 points 2.18 1.40–3.41 1.17 0.76–1.79
SF-36 — Short Form 36; OR — odds ratio; CI — confidence interval; BDI — Beck Depression Inventory
Table 5. Correlation coefficients r of predictors measured baseline with physical component summary (PCS) and mental component sum-
mary (MCS) after 6th month follow-up
Variables 6th month follow-up
SF-36 PCS SF-36 MCS
F M F M
Age (year of life) –0.394 –0.079 0.065 0.197
BMI [kg/m2] –0.129 –0.056 0.219 –0.157
WHR [cm/cm] –0.259 –0.166 0.056 –0.239
Pack years (20 cigarettes/day/years) 0.074 –0.075 –0.057 0.059
BDI (points) –0.318 –0.402 –0.323 –0.144
Values r significant at level p < 0.05 marked with bold; SF-36 — Short Form 36; F — female; M — male; BMI — body mass index; WHR — waist hip ratio
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diseases among women at the time of initial diagnosis of 
ACS and by a worse degree of their functioning as compa-
red to men [22].
In our study women were 8 years older than men at 
the time of ACS diagnosis. Furthermore, they presented 
with a greater number of concomitant diseases (diabetes 
and hypertension).
Lower HRQoL of women can be explained by higher 
prevalence of depressive symptoms in this group, lower 
educational level, and limitations of physical and social acti-
vity, causing increased escalation of stress and frustration 
[6]. In the present study, women were more likely to have 
primary education and did not engage in physical activity.
Dias et al. [3] investigated a group of 278 patients tre-
ated for ACS and identified female gender and symptoms 
of depression as predictors of worse mental health scores. 
In contrast, male gender, higher levels of education, and 
lack of cardiovascular incidents turned out to be predictors 
of higher physical health scores [3].
In our study, age over 70 constituted a determinant 
negatively affecting 6th month follow-up HRQoL.
Our results are consistent with the findings of Beck et 
al, who noted that younger age and higher baseline level 
of HRQoL constitute predictors of better HRQoL, especially 
PCS, 6 and 12 months after ACS [23].
However, Brown et al. reported contradictory findings 
as they observed that patients under 55 years of age eva-
luated their quality of life as poorer than older people. This 
can be explained by limitations in fulfilling professional and 
social activities [21].
Noticeably, our patients with NSTEMI had lower PCS 
scores at 6th month follow-up. However our work did not 
prove the impact of NSTEMI as a predictor of decreased 
HRQoL at 6th month follow-up. Poloński et al. [24] made 
comparisons between ST elevation and non-ST elevation 
myocardial infarction using a large registry database. They 
observed that non-ST myocardial infarction was associated 
with worse long-term prognosis [24].
Numerous studies in literature indicate that the worse 
long-term results in patients with NSTEMI may be associa-
ted with worse overall health of these group of patients.
The reasons for poorer HRQoL at 6th month follow-up 
remain unclear. This phenomenon may be explained by un-
favourable clinical characteristics of patients with NSTEMI. 
According to Park et al. [25], NSTEMI can be associated 
with greater number of co-morbidities.
The effect of diabetes on HRQoL in patients with ACS 
remains controversial. In our univariate analysis, patients 
with diabetes and hypertension had lower PCS, but the 
difference turned out to be statistically insignificant.
The hereby presented results are consistent with the 
findings of our previous study, which showed that patients 
with ACS and diabetes report lower HRQoL than those 
without this condition. However, although individuals 
with diabetes showed lower HRQoL, this condition did 
not prove to be an independent determinant of lower 
HRQoL [26].
In contrast, Dias et al. reported that diabetes, arterial 
hypertension, and loneliness constitute predictors of decre-
ased PCS scores in patients with ACS [3] and Schweikert 
et al. revealed that diabetes, older age, tobacco smoking, 
and increased BMI represent the main predictors of decre-
ased QoL [27].
It is known that elevated depressive symptom have 
been associated with higher risk of adverse outcomes in 
both men and women with ACS [15, 16]. Higher BDI scores 
(≥ 10 points) turned out to be associated with decreased 
PCS in both univariate and multivariate analysis. Rumsfeld 
et al. [4] observed that 7 months following ACS, patients 
with depression show more frequent and severe symptoms 
of angina, more serious limitations on physical activity, and 
significantly lower HRQoL scores than individuals without 
depression.
de Jonge et al. [28] found a significant correlation 
between depression after myocardial infarction and 
poorer HRQoL, lower level of health-related satisfa-
ction, higher rate of stenocardia, and higher degree of 
disability. Moreover, they observed a strong correlation 
between pre-infarction depression rate and lower HRQoL 
scores three months after the myocardial infarction. 
According to these authors, depression not only results 
from poorer health, but also can negatively affect one’s 
health status [28].
Marital status (being lone) was also shown to exert 
a negative effect on HRQoL. In our study, the lone pa-
tients showed lower PCS than individuals who remained 
in relationships. Loneliness turned out to be a predictor 
of decreased PCS on both univariate and multivariate 
analysis. Also Dias et al. reported that lower PCS scores 
are characteristic for lonely people [3].
Overweight and abdominal obesity constituted predic-
tors of lower HRQoL. We found that women had higher BMI. 
Although a negative correlation of WHR with PCS and MCS 
was observed, neither BMI nor WHR proved to be predictors 
of lower HRQoL in multivariate analysis.
Our univariate analysis revealed that non-smoking 
was a predictor of decreased PCS score. Active smokers 
have higher PCS scores than non-smokers. However 
in the multifactorial analysis, smoking status was not 
a predictor of affecting the assessment of HRQoL. These 
findings are consistent with the so-called smoker’s pa-
radox. According to CADILLAC registry, mortality rates of 
smokers are lower compared to non-smokers; however, 
this difference was no longer present after adjustment to 
younger age and fewer co-morbidities of smokers. Among 
smokers, female gender was a significant risk factor for 
adverse cardiovascular events at 6th month follow-up 
after ACS [29].
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The lack of separate gender characteristics for smokers 
and non-smokers is a potential limitation of our study. Mo-
reover, we did not analyse the number of cigarettes smoked 
or duration of smoking. The smoking status on admission 
was assessed only as a binary variable (current vs. never 
or former smoker).
Our findings warrant additional evaluation and further 
study of potential gender-related differences in the risks of 
smoking in a larger cohort of patients with ACS.
In summary, we revealed that the female gender and age 
over 70 are significant predictors of lower PCS and also MCS 
scores. After adjusting for confounding variables (Mantel-
-Haenszel odds ratio), the impact of female gender was 
decreased, albeit still statistically significant. Women with 
ACS had worse risk profile, show less favourable clinical cha-
racteristics and greater number of comorbidities. Therefore, 
it is surprising that diabetes and hypertension did not exert 
significant effect on PCS. Whereas, sociodemographic and 
psychological predictors, such as lack of marital status and 
symptoms of depression, had negative impact on HRQoL.
Implications
Our findings may affect the need to implement psychologi-
cal care, leading to early diagnosis of factors intensifying 
symptoms of depression, social support, and furthermore 
the need for screening and therapeutic actions oriented 
mainly on females.
Understanding gender-specific differences in HRQoL 
may have clinical significance and may affect developing 
individual approaches to therapy, secondary prevention, 
and rehabilitation after myocardial infarction [3].
The strong influence of sociodemographic predictors 
(lone, retirement) and symptoms of depression suggest that 
it would be beneficial to encourage patients to participate 
in cardiac rehabilitation programs, and to early resume the 
occupational and daily-life activity.
Limitations
Potential limitations of our study include lack of control 
group, lack of reference levels of HRQoL for population of 
healthy individuals, and too short duration of the follow-
-up period. Also, the pre-infarction level of HRQoL of study 
participants remains unknown.
Conclusions
Among the patients with ACS treated by PCI, women showed 
lower HRQoL than men, both at baseline and at 6th month 
follow-up. Although women and men showed improvement 
in PCS scores at follow-up examination, MCS improvement 
was observed only for women. The significant baseline pre-
dictors of 6th month follow-up HRQoL were female gender, 




Wstęp. Niewiele jest publikacji, w których dokonuje się analizy porównawczej wczesnej i odległej jakości życia (QoL) 
zależnie od płci w ostrym zespole wieńcowym (ACS) oraz analizuje wyznaczniki odległej QoL. Autorzy postawili hipotezę, 
że kobiety po ACS leczone z zastosowaniem przezskórnej interwencji wieńcowej (PCI) charakteryzują gorsze wyniki 
odległej QoL.
Celem pracy było zbadanie dynamiki zmian jakości życia po 6 miesiącach od PCI zależnie od płci oraz identyfikacja pre-
dyktorów (baseline) socjodemograficznych i klinicznych, które mogą wpływać na odległą QoL chorych hospitalizowanych 
z powodu ACS, poddawanych zabiegom angioplastyki wieńcowej.
Materiał i metody. Badania przeprowadzono u 140 pacjentów (70 kobiet, 70 mężczyzn) hospitalizowanych z powodu 
ACS poddawanych zabiegom PCI. Chorych podzielono na dwie grupy: grupę I (n = 70) — kobiety z ACS bez uniesienia 
ST (NSTEMI; n = 14) i z uniesieniem ST (STEMI; n = 56), grupę II (n = 70) — mężczyzn w wieku 32–95 lat (śr. wieku 
59,2) z ACS bez uniesienia ST (NSTEMI; n = 9) i z uniesieniem ST (STEMI; n = 61). Jakość życia oceniano dwukrotnie 
(w pierwszym tygodniu po ACS i 6 miesięcy później) za pomocą kwestionariusza SF-36.
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Wyniki. W porównaniu z mężczyznami u kobiet ocena jakości życia w wymiarze fizycznym (PCS) i psychicznym (MCS) 
była znacząco niższa zarówno w ocenie wyjściowej, jak i follow-up. W analizie jednoczynnikowej niższe wyniki odległej 
QoL w domenie PCS dotyczyły kobiet, osób powyżej 70. roku życia, nieaktywnych fizycznie, niepalących, na emeryturze 
i z rozpoznanymi objawami depresji. Z kolei w domenie MCS w analizie jednoczynnikowej nie zanotowano istotnego 
wpływu analizowanych zmiennych na QoL. W analizie wieloczynnikowej za istotne statystycznie predyktory QoL w dome-
nach PCS i MCS w badaniu follow-up uznano płeć żeńską i wiek ponad 70 lat. Dodatkowo stan cywilny i depresja były 
predyktorami negatywnie wpływającymi na QoL w domenie PCS.
Wnioski. Wśród chorych z ACS kobiety cechowała niższa QoL niż badanych mężczyzn, zarówno w badaniu wyjściowym, 
jak i obserwacji follow-up. Obie badane grupy wykazały poprawę QoL w domenie PCS w badaniu follow-up, ale w do-
menie MCS poprawa ta dotyczyła jedynie badanych kobiet. Istotnym statystycznie predyktorem wpływającym na QoL 
6 miesięcy po PCI były płeć żeńska, wiek i stan cywilny.
Słowa kluczowe: jakoś życia związana ze stanem zdrowia, ostry zespół wieńcowy, różnice płci
(Folia Cardiologica 2014; 9, 3: 213–226)
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Klinika Chorób Wewnętrznych i Rehabilitacji Kardiologicznej  
Uniwersytetu Medycznego w Łodzi
W pracy autorstwa Beaty Jankowskiej-Polańskiej i wsp. podjęto ważki temat zróżnicowa-
nego klinicznego przebiegu choroby wieńcowej u mężczyzn i kobiet.
Należy przypomnieć, że w Polsce nadal więcej kobiet niż mężczyzn umiera z powodu 
chorób układu sercowo-naczyniowego [1].
Ostry zespół wieńcowy (ACS, acute coronary syndrome) u kobiet, zwłaszcza w ostatnich 
latach, jest problemem szczególnie docenianym przez kardiologów. Zaobserwowano 
bowiem, że z uwagi na płeć istnieją znaczące różnice zarówno pod względem stwierdza-
nych objawów, znaczenia markerów diagnostycznych, działań niepożądanym stosowanej terapii farmakologicznej, jak 
i występowania powikłań. W odniesieniu do czynników ryzyka sercowego kobiety, szczególnie starsze, cechuje wyższe 
ryzyko na przykład cukrzycy [2]. Według badań GUSTO IIb oraz TIMI IIIB 2 u kobiet częściej rozpoznaje się niestabilną 
dławicę piersiową i zawał serca bez uniesienia odcinka ST (NSTEMI, non-ST-elevation myocardial infarction). Natomiast 
u mężczyzn częściej występuje zawał pełnościenny (STEM, ST-elevation myocardial infarction) [3, 4]. Wiadomo rów-
nież, że śmiertelność chorych z NSTEMI jest podobna zarówno w grupie mężczyzn, jak i kobiet. Z kolei jednak w grupie 
chorych z STEMI jest zdecydowanie większa wśród kobiet.
W praktyce klinicznej kobiety częściej zgłaszają dolegliwości, które początkowo bywają bagatelizowane. Ból, jeśli wystę-
puje, to ma charakter nietypowy, jest umiejscowiony w okolicy potylicznej lub jamy brzusznej. Często zgłaszane objawy 
to duszność, zawroty głowy, osłabienie czy zaburzenia koncentracji. Taki opis klinicznej manifestacji objawów trudno 
uznać za charakterystyczny dla choroby niedokrwiennej mięśnia sercowego. Warto zwrócić uwagę na subiektywne do-
legliwości podawane przez chore, takie jak uczucie zmęczenia czy zaburzenia snu. Okazuje się, że w wielu przypadkach 
są to wczesne objawy ACS, poprzedzające jego wystąpienie u kobiet nawet o kilka tygodni [5].
Autorzy za cel pracy postawili sobie zbadanie dynamiki zmian jakości życia po 6 miesiącach od ACS zaopatrzonego za 
pomocą przezskórnej interwencji wieńcowej (PCI, percutaneous coronary intervention) zależnie od płci oraz identyfi-
kację predykatorów socjologicznych, demograficznych i klinicznych, które mogą wpływać na odległą jakość życia (QoL, 
quality of life). W kontekście przytoczonych wyżej rozważań podjęcie badań wydaje się w pełni uzasadnione. I to mimo, 
że w doniesieniach z ubiegłej dekady pojawiały się dane ukazujące niższą QoL między innymi u kobiet z nadciśnie-
niem tętniczym w porównaniu z mężczyznami, które wykazywały tendencję wzrostową z wiekiem badanych. Wartość 
podjętego przez Autorów trudu uzasadnia zatem fakt zmieniających się cech populacyjnych i warunków demograficz-
nych. Rosnąca systematycznie długość życia populacji europejskiej oraz zagrożenie depresją, zwłaszcza wśród kobiet 
w Polsce, to ważne czynniki upoważniające do systematycznego aktualizowania posiadanej wiedzy. W pewnym stopniu 
wyniki badań Autorów korespondują z wcześniej publikowanymi i potwierdzają niższą QoL kobiet w porównaniu z męż-
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czyznami po przebytym ACS. Dotyczy to zarówno sfery fizycznej, jak i psychicznej. Warto podkreślić, że wiek badanych 
przekraczający 70 lat oraz płeć żeńska stanowiły istotne predykatory obniżonej QoL. Potwierdzona depresja, z kolei, 
istotnie obniżała samoocenę, zwłaszcza w sferze fizycznej, wpływając na postrzeganie siebie przez kobiety jako osoby 
bardziej chore niż w rzeczywistości.
Wartością dodaną przedstawionej pracy są wyniki obserwacji follow-up. Pocieszający jest bowiem fakt poprawy QoL 
zarówno w grupie mężczyzn, jak i kobiet po upływie 6 miesięcy od incydentu wieńcowego. Jednak, biorąc pod uwagę 
wpływ badanych zmiennych QoL, kobiety są grupą wymagająca szczególnej uwagi zarówno pod względem kardiolo-
gicznym, jak i długoterminowej opieki psychologicznej.
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